Zenith Health Care Ltd Stock Price Today (NSE: ZENITHHE)
Fundamental Score
Zenith Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Zenith Health Care Ltd share price today is ₹3.12, down 1.58% on NSE/BSE as of 17 June 2026. Zenith Health Care Ltd (ZENITHHE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹19.72 (Cr). The 52-week high for ZENITHHE share price is ₹4.99 and the 52-week low is ₹2.23. The company has a Return on Equity (ROE) of 0.81% and a debt-to-equity ratio of 0.00.
Zenith Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Zenith Health Care Ltd share price chart: 33.47% return over the past month. 52-week high ₹4.99, 52-week low ₹2.23.
Zenith Health Care Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹3.30 | ₹3.31 | ₹3.22 | ₹3.23 | 17.93K (Cr) | |
| ₹3.24 | ₹3.25 | ₹3.20 | ₹3.23 | 20.04K (Cr) | |
| ₹3.17 | ₹3.17 | ₹3.15 | ₹3.17 | 14.04K (Cr) | |
| ₹3.18 | ₹3.23 | ₹3.10 | ₹3.17 | 7.26K (Cr) | |
| ₹3.15 | ₹3.22 | ₹3.12 | ₹3.16 | 31.11K (Cr) | |
| ₹3.15 | ₹3.34 | ₹3.15 | ₹3.17 | 29.34K (Cr) | |
| ₹3.35 | ₹3.35 | ₹3.02 | ₹3.15 | 27.41K (Cr) | |
| ₹3.23 | ₹3.34 | ₹3.15 | ₹3.18 | 48.15K (Cr) | |
| ₹3.37 | ₹3.37 | ₹3.16 | ₹3.28 | 10.51K (Cr) | |
| ₹3.43 | ₹3.43 | ₹3.26 | ₹3.29 | 14.61K (Cr) |
Zenith Health Care Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹2.40 | ₹3.59 | ₹2.40 | ₹3.23 | +34.58% | |
| ₹3.26 | ₹3.58 | ₹2.23 | ₹2.42 | -25.77% | |
| ₹3.34 | ₹3.85 | ₹3.11 | ₹3.30 | -1.20% | |
| ₹3.36 | ₹4.12 | ₹3.19 | ₹3.36 | +0.00% | |
| ₹3.70 | ₹3.84 | ₹3.05 | ₹3.35 | -9.46% | |
| ₹3.97 | ₹3.99 | ₹3.20 | ₹3.74 | -5.79% | |
| ₹4.20 | ₹4.35 | ₹3.70 | ₹3.94 | -6.19% | |
| ₹4.01 | ₹4.99 | ₹4.01 | ₹4.21 | +4.99% | |
| ₹4.09 | ₹4.62 | ₹3.33 | ₹4.27 | +4.40% | |
| ₹4.25 | ₹4.47 | ₹3.92 | ₹4.03 | -5.18% | |
| ₹4.56 | ₹4.56 | ₹4.01 | ₹4.40 | -3.51% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Microcap pharma play with brutal headwinds and questionable execution.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Stock is down 3.31% on April 7, 2026, closing at Zenith Health Care announced stable Q3 results (ending February 2025) but its evaluation score decreased, signaling potential shifts in financial health and market position.
CORE STORY (THE REAL GAME)
Zenith Health Care is a micro-cap play on contract manufacturing and exports of generic formulations to developing markets. The real game is whether they can scale operations and improve profitability in a highly competitive landscape.
- Generic export growth potential
- Contract manufacturing diversification
- Low base effect offers potential for turnaround
- Significant new export contracts
- Successful backward integration into APIs
- Improved quarterly earnings
- Microcap liquidity risk
- Negative sales and profit CAGR
- Low ROE and high P/E
Promoter holding stable at 28.74%. No significant FII/DII activity.
Indian pharma exports are growing, but pricing pressures and trade uncertainties remain.
No. Free Cash Flow 5Y: ₹0.38 Cr.
3-6 month thesis hinges on securing new contracts and demonstrating improved profitability. Failure to do so will likely lead to further downside.
Primary Thesis Risk
Inability to scale operations and improve profitability will lead to value erosion.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Zenith Health Care Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Zenith Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZENITHHE across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (55.56%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
10 factors identified
Below-Average Return on Equity (0.81%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (1.56%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-25.08%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-1.11% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-36.25% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-36.25% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Low Promoter Commitment (28.74%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 0.39%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Zenith Health Care Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Zenith Health Care Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Zenith Health Care LtdZenith Health C...Selected✓ ZENITHHE • 530665 | 9.5/100 | ₹3.12₹3 | ₹19.72₹19.72 | — — | 0.81%Poor 0.81% Poor | 3.12%Poor 3.12% Poor | 0.00Excellent 0.0 Excellent | -36.25%Poor -36.25% Poor | -1.11%Poor -1.11% Poor | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Zenith Health Care Ltd PE Ratio History
Historical price-to-earnings ratio for ZENITHHE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.04 | ₹5.17 | 136.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Zenith Health Care Ltd Quarterly Performance
Latest quarterly metrics for ZENITHHE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-25.08%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
55.56%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-1.11%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-36.25%
Compounded annual net profit growth over 5 years
Zenith Health Care Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ZENITHHE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Zenith Health Care Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Zenith Health Care Ltd (ZENITHHE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Zenith Health Care Ltd
About ZENITHHE (Zenith Health Care Ltd)
Zenith Health Care Ltd is a dynamic pharmaceutical entity operating within the vibrant Indian healthcare landscape. Focusing on both production and distribution, Zenith specializes... in crafting a diverse portfolio of pharmaceutical formulations. Their product range encompasses a variety of delivery methods including conventional tablets and capsules, easily administered oral liquids designed for palatability and ease of use, and sterile injectables meeting stringent safety protocols. Zenith's operational model extends beyond its own branded product lines, incorporating contract manufacturing services where they leverage their manufacturing expertise for other pharmaceutical companies, contributing to the broader pharmaceutical supply chain. They are known for their adherence to international quality standards and cost-effective production. Zenith Health Care has strategically established a robust international presence, exporting its pharmaceutical products to a wide array of global markets. Their distribution network extends across multiple continents, reaching countries spanning Southeast Asia, Africa, and Latin America. Within Southeast Asia, Zenith supplies essential medicines to nations like Cambodia and Myanmar, while also contributing to healthcare provision in Papa New Guinea and Sri Lanka. Their African market presence is substantial, with a significant supply chain reaching countries such as Kenya, Nigeria, Gambia, Zambia, Namibia, and Botswana. Further demonstrating its global reach, Zenith has established distribution channels in Armenia, Georgia, Uzbekistan, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen, and Turkey. Zenith Health Care operates with a commitment to quality and affordability, striving to make essential medicines accessible to a global population. By offering a diverse range of dosage forms and engaging in contract manufacturing, Zenith strategically positions itself as a versatile player in the pharmaceutical sector. Their focus on international markets and expansion into diverse regions underscores a mission to address global health challenges and meet the growing demand for reliable and affordable healthcare solutions. With a growing reputation for regulatory compliance and efficacy, Zenith Health Care continues to expand its manufacturing capabilities and strategic distribution networks, ensuring a sustainable future in the pharmaceutical landscape.
Company Details
Key Leadership
ZENITHHE Share Price: Frequently Asked Questions
What is the current share price of Zenith Health Care Ltd?
Zenith Health Care Ltd (ZENITHHE) trades at ₹3.12 on NSE and BSE. Market cap ₹19.72 (Cr). Educational data only.
What is the P/E ratio of Zenith Health Care Ltd?
Zenith Health Care Ltd has a P/E of N/Ax vs industry average 31.77x.
What is the Bull Run score for Zenith Health Care Ltd?
Zenith Health Care Ltd has a Bull Run score of 9.5/100 based on 25+ financial parameters.
Does Zenith Health Care Ltd pay dividends?
Zenith Health Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Zenith Health Care Ltd?
Zenith Health Care Ltd has ROE of 0.81%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Zenith Health Care Ltd?
Zenith Health Care Ltd has debt-to-equity of 0.00.
Is Zenith Health Care Ltd a good investment?
Bull Run gives Zenith Health Care Ltd a score of 9.5/100. This is not investment advice — consult a SEBI-registered advisor.